Literature DB >> 6628522

Bioavailability of metoprolol in young adults and the elderly, with additional studies on the effects of metoclopramide and probanthine.

R H Briant, R E Dorrington, D G Ferry, J W Paxton.   

Abstract

The bioavailability of metoprolol was studied in eight healthy young and seven healthy elderly volunteers. Large interindividual differences in the bioavailability of metoprolol were observed in both groups. However, there was no significant difference in AUC, peak plasma concentration or elimination half-life between young and elderly, but time to peak concentration was significantly longer in the elderly. Pretreatment with metoclopramide had no effect on AUC but caused significant increases in peak concentration and decreases in time to peak concentration in both groups. Probanthine pretreatment (only to the young) resulted in a significant decrease in peak concentration of metoprolol and a significant increase in time to peak concentration but had no effect on the AUC. These results suggest that alterations in gastric emptying and gut motility due to ageing or other drugs have no effect on the overall availability of metoprolol to the systemic circulation but may have significant effects on the time to peak plasma concentration and peak concentration achieved after a single oral dose.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628522     DOI: 10.1007/bf01037947

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Plasma metoprolol concentrations in young, old and hypertensive subjects.

Authors:  M J Kendall; D Brown; R A Yates
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

2.  The possible role of cytochrome P-450 in the liver "first pass elimination" of a beta-receptor blocking drug.

Authors:  R Grundin; P Moldéus; S Orrenius; K O Borg; I Skånberg; C von Bahr
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-09

3.  The disposition of propranolol. I. Elimination during oral absorption in man.

Authors:  D G Shand; R E Rangno
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

4.  Effect of age on intestinal absorption: implications for drug absorption in the elderly.

Authors:  A D Bender
Journal:  J Am Geriatr Soc       Date:  1968-12       Impact factor: 5.562

5.  Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.

Authors:  M S Lennard; J H Silas; S Freestone; J Trevethick
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

6.  The disposition of propranolol. VII. The effects of saturable hepatic tissue uptake on drug clearance by the perfused rat liver.

Authors:  D G Shand; R A Branch; G H Evans; A S Nies; G R Wilkinson
Journal:  Drug Metab Dispos       Date:  1973 Sep-Oct       Impact factor: 3.922

Review 7.  Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

Authors:  G Johnsson; C G Regàrdh
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of propranolol.

Authors:  P A Routledge; D G Shand
Journal:  Clin Pharmacokinet       Date:  1979 Mar-Apr       Impact factor: 6.447

9.  Pharmacological modification of gastric emptying: effects of propantheline and metoclopromide on paracetamol absorption.

Authors:  J Nimmo; R C Heading; P Tothill; L F Prescott
Journal:  Br Med J       Date:  1973-03-10

10.  The effect of age on the pharmacokinetics of metoprolol and its metabolites.

Authors:  C P Quarterman; M J Kendall; D B Jack
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

View more
  8 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.

Authors:  Peer Tfelt-Hansen; Frederik Nybye Ågesen; Agniezka Pavbro; Jacob Tfelt-Hansen
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

4.  Drug interaction between propafenone and metoprolol.

Authors:  F Wagner; D Kalusche; D Trenk; E Jähnchen; H Roskamm
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

5.  Metoprolol in acute myocardial infarction. A pharmacokinetic and pharmacodynamic study.

Authors:  P H Held; C G Regårdh
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Influence of smoking and gender on the disposition kinetics of metoprolol.

Authors:  L J Schaaf; S C Campbell; M B Mayersohn; T Vagedes; D G Perrier
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Severe complications of antianginal drug therapy in a patient identified as a poor metabolizer of metoprolol, propafenone, diltiazem, and sparteine.

Authors:  F Wagner; E Jähnchen; D Trenk; M Eichelbaum; P Harnasch; G Hauf; H Roskamm
Journal:  Klin Wochenschr       Date:  1987-12-15

Review 8.  Magnitude of Drug-Drug Interactions in Special Populations.

Authors:  Sara Bettonte; Mattia Berton; Catia Marzolini
Journal:  Pharmaceutics       Date:  2022-04-04       Impact factor: 6.525

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.